Pharmaceutical

What’s on tap at HLTH, the health care industry jamboree that kicks off this weekend

What’s on tap at HLTH, the health care industry jambore...

Oct 6, 2023

What's on tap at HLTH, the health care industry jamboree that kicks off this wee...

STAT+: FDA advisory panel signals lack of confidence in data on Amgen’s cancer drug

STAT+: FDA advisory panel signals lack of confidence in...

Oct 6, 2023

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakie...

FDA expert panel endorses idea of removing a component from flu vaccine

FDA expert panel endorses idea of removing a component ...

Oct 6, 2023

The FDA's expert vaccine advisory panel unanimously endorsed the idea of taking ...

Listen: Is the Nobel committee evolving? Plus, preventing public health’s wiliest virus

Listen: Is the Nobel committee evolving? Plus, preventi...

Oct 6, 2023

Listen: Is the Nobel committee evolving? Will we ever have an HIV vaccine?

STAT+: Neurocrine reports second late-stage trial success for congenital adrenal hyperplasia drug

STAT+: Neurocrine reports second late-stage trial succe...

Oct 6, 2023

Neurocrine Biosciences announced that its experimental drug for congenital adren...

STAT+: Telehealth claims data suggest service duplication, Roche app to evaluate MS symptom

STAT+: Telehealth claims data suggest service duplicati...

Oct 6, 2023

In the latest edition of STAT's Health Tech newsletter: telehealth creating serv...

The future of health care in the House

The future of health care in the House

Oct 6, 2023

House Speaker candidates Reps. Steve Scalise (R-La.) and Jim Jordan (R-Ohio) hav...

Moderna’s plan to make a single vaccine for Covid, influenza, and RSV is on track

Moderna’s plan to make a single vaccine for Covid, infl...

Oct 6, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages

STAT+: Pharmalittle: Novo faces patent challenge on Weg...

Oct 6, 2023

A U.S. Patent Office tribunal agreed to review the validity of a Novo Nordisk pa...

Cancer drug shortage eases slightly, but it’s still ‘living from paycheck to paycheck’

Cancer drug shortage eases slightly, but it’s still ‘li...

Oct 6, 2023

“Sometimes we have to look for completely different chemotherapy regimens that m...

Lumicell co-founder wins Nobel Prize in Chemistry

Lumicell co-founder wins Nobel Prize in Chemistry

Oct 5, 2023

The co-founder of a fluorescence-guided imaging technology firm has been awarde...

Japanese Kyowa Kirin acquires Orchard to bolster gene therapy pipeline

Japanese Kyowa Kirin acquires Orchard to bolster gene t...

Oct 5, 2023

The Japan-based pharmaceutical company Kyowa Kirin has entered into a defin...

AstraZeneca’s Forxiga meets primary endpoint for T2D

AstraZeneca’s Forxiga meets primary endpoint for T2D

Oct 5, 2023

AstraZeneca has announced positive results from the T2NOW Phase III trial for p...

EMA endorses Calliditas’ Alport syndrome drug for orphan designation

EMA endorses Calliditas’ Alport syndrome drug for orpha...

Oct 5, 2023

The European Medicines Agency (EMA) has provided a positive opinion for Callidi...

Inhibikase’s risvodetinib wins FDA orphan drug designation

Inhibikase’s risvodetinib wins FDA orphan drug designation

Oct 5, 2023

The US Food and Drug Administration (FDA) has granted Inhibikase Therapeutics’ ...

Advanz Pharma to license Dimerix’s DMX-200 drug candidate

Advanz Pharma to license Dimerix’s DMX-200 drug candidate

Oct 5, 2023

Advanz Pharma has signed an agreement to licence Dimerix’s drug candidate DMX-2...